Kevin Ferro

Insider Reports History

Entity
Individual
Location
C/O Kos Pharmaceuticals, Inc., 1001 Brickell Bay Drive, 25 Th Floor, Miami, FL
Signature
/s/ Mark R. Lasky, Attorney-in-Fact for Kevin Ferro
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Ferro:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GREENHILL & CO INC Director Common Stock 0 $14.61 Nov 30, 2023 By grantor retained annuity trust
GREENHILL & CO INC Director Common Stock 0 $14.61 Nov 30, 2023 Direct

Insider Reports Filed by Kevin Ferro

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GHL GREENHILL & CO INC Nov 30, 2023 2 $0 4 Dec 1, 2023 Director
GHL GREENHILL & CO INC Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
GHL GREENHILL & CO INC Jan 4, 2023 1 $0 4 Jan 5, 2023 Director
GHL GREENHILL & CO INC Oct 4, 2022 1 $0 4 Oct 6, 2022 Director
GHL GREENHILL & CO INC Jul 5, 2022 1 $0 4 Jul 7, 2022 Director
GHL GREENHILL & CO INC May 2, 2022 1 $122K 4 May 4, 2022 Director
GHL GREENHILL & CO INC Apr 5, 2022 1 $0 4 Apr 6, 2022 Director
GHL GREENHILL & CO INC Jan 4, 2022 1 $0 4 Jan 5, 2022 Director
GHL GREENHILL & CO INC Oct 5, 2021 1 $0 4 Oct 7, 2021 Director
GHL GREENHILL & CO INC Jul 2, 2021 1 $0 4 Jul 6, 2021 Director
GHL GREENHILL & CO INC May 7, 2021 3 $674K 4 May 11, 2021 Director